Find a Clinical Trial
Filter
Multi-spectral imaging
Ovarian cancer
Female
18-99
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Breast cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
PBCAR0191
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
NRG-BN009
Brain cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
ON-TRK
Solid tumors
All genders
No minimum age
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
BCL Study
Breast cancer
Female
18+
Recruiting now
Department of Surgery
REACH Lupus Study
Systemic lupus erythematosus
All genders
18+
Recruiting now
Division of Rheumatology
TAICHIKNEE
Arthritis
All genders
50+
Recruiting now
Division of Rheumatology
S1925
Chronic lymphocytic leukemia (CLL), Lymphoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma (XPORT-EC-042)
Endometrial cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center